Aricept, Donepezil News

Objective: Since cholinergic deficits are prominent in dementia with Lewy bodies , we investigated the effects of a cholinesterase inhibitor, donepezil, in such patients in a randomized, double-blind, placebo-controlled exploratory phase II trial.

The race to find a complete cure has brought news over the last two years of a new safe and non-invasive claim of a wonder drug created from P7C3 that has been successful in treating rats.

In a major setback for patients and doctors, drugmakers Pfizer Inc. and Medivation Inc.

Background: A recent randomized clinical trial raised a concern about the safety of rivastigmine, one of the drugs used to treat dementia.

In a major setback for patients and doctors, drugmakers Pfizer Inc. and Medivation Inc.